The Biomarker: Melanoma

Sanjiv S. Agarwala, MD
Video Categories: The Biomarker

PMO is pleased to offer the department “The Biomarker” to discuss the identification of biomarkers in patients with cancer and the prognostic/predictive impact and clinical decision-making implications of that marker. This month, we focus on KIT mutations in melanoma patients. Dr Sanjiv Agarwala provides his insights on this provocative topic.
October 28, 2014

Unmet Clinical Needs in Polycythemia Vera

Dr. Mesa discusses what approaches in therapy he takes for PV patients with unmet clinical needs such as recurrent vascular events.Supported through funding from Incyte

January 30, 2014

Personalized Medicine and the Impact on the Pharmaceutical Company

Dr Agarwala hypothesizes how the future of the traditional pharmaceutical company may change with the developments in personalized medicine.